318 related articles for article (PubMed ID: 16427098)
1. Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Pisanu A; Acquas E; Fenu S; Di Chiara G
Neuropharmacology; 2006 May; 50(6):661-70. PubMed ID: 16427098
[TBL] [Abstract][Full Text] [Related]
2. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens.
Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N
Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831
[TBL] [Abstract][Full Text] [Related]
3. Effects of neonatal ventral hippocampal lesion in rats on stress-induced acetylcholine release in the prefrontal cortex.
Laplante F; Stevenson CW; Gratton A; Srivastava LK; Quirion R
J Neurochem; 2004 Dec; 91(6):1473-82. PubMed ID: 15584923
[TBL] [Abstract][Full Text] [Related]
4. Alterations in dopaminergic modulation of prefrontal cortical acetylcholine release in post-pubertal rats with neonatal ventral hippocampal lesions.
Laplante F; Srivastava LK; Quirion R
J Neurochem; 2004 Apr; 89(2):314-23. PubMed ID: 15056275
[TBL] [Abstract][Full Text] [Related]
5. Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.
Khaimova E; Kandov Y; Israel Y; Cataldo G; Hadjimarkou MM; Bodnar RJ
Brain Res; 2004 Nov; 1026(2):284-94. PubMed ID: 15488491
[TBL] [Abstract][Full Text] [Related]
6. The non-peptidic delta opioid receptor agonist TAN-67 enhances dopamine efflux in the nucleus accumbens of freely moving rats via a mechanism that involves both glutamate and free radicals.
Fusa K; Takahashi I; Watanabe S; Aono Y; Ikeda H; Saigusa T; Nagase H; Suzuki T; Koshikawa N; Cools AR
Neuroscience; 2005; 130(3):745-55. PubMed ID: 15590157
[TBL] [Abstract][Full Text] [Related]
7. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
Cadoni C; Valentini V; Di Chiara G
J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
[TBL] [Abstract][Full Text] [Related]
8. Potentiation of dopamine D1-like receptor signaling by concomitant activation of δ- and μ-opioid receptors in mouse medial prefrontal cortex.
Olianas MC; Dedoni S; Onali P
Neurochem Int; 2012 Dec; 61(8):1404-16. PubMed ID: 23073238
[TBL] [Abstract][Full Text] [Related]
9. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.
MacDonald AF; Billington CJ; Levine AS
Brain Res; 2004 Aug; 1018(1):78-85. PubMed ID: 15262208
[TBL] [Abstract][Full Text] [Related]
10. 3,4-Methylenedioxymethamphetamine (MDMA) enhances the release of acetylcholine by 5-HT4 and D1 receptor mechanisms in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Synapse; 2005 Dec; 58(4):229-35. PubMed ID: 16206181
[TBL] [Abstract][Full Text] [Related]
11. Beta-endorphin elevations in the ventral tegmental area regulate the discriminative effects of Delta-9-tetrahydrocannabinol.
Solinas M; Zangen A; Thiriet N; Goldberg SR
Eur J Neurosci; 2004 Jun; 19(12):3183-92. PubMed ID: 15217374
[TBL] [Abstract][Full Text] [Related]
12. Activation of 5-HT2 receptors enhances the release of acetylcholine in the prefrontal cortex and hippocampus of the rat.
Nair SG; Gudelsky GA
Synapse; 2004 Sep; 53(4):202-7. PubMed ID: 15266551
[TBL] [Abstract][Full Text] [Related]
13. NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release.
Zmarowski A; Sarter M; Bruno JP
Eur J Neurosci; 2005 Oct; 22(7):1731-40. PubMed ID: 16197513
[TBL] [Abstract][Full Text] [Related]
14. Nonstriatal dopamine D1 receptors regulate striatal acetylcholine release in vivo.
Acquas E; Wilson C; Fibiger HC
J Pharmacol Exp Ther; 1997 Apr; 281(1):360-8. PubMed ID: 9103518
[TBL] [Abstract][Full Text] [Related]
15. mu- but not delta- and kappa-opioid receptors in the ventrolateral orbital cortex mediate opioid-induced antiallodynia in a rat neuropathic pain model.
Zhao M; Wang JY; Jia H; Tang JS
Brain Res; 2006 Mar; 1076(1):68-77. PubMed ID: 16476416
[TBL] [Abstract][Full Text] [Related]
16. Implication of dopaminergic projection from the ventral tegmental area to the anterior cingulate cortex in μ-opioid-induced place preference.
Narita M; Matsushima Y; Niikura K; Narita M; Takagi S; Nakahara K; Kurahashi K; Abe M; Saeki M; Asato M; Imai S; Ikeda K; Kuzumaki N; Suzuki T
Addict Biol; 2010 Oct; 15(4):434-47. PubMed ID: 20731628
[TBL] [Abstract][Full Text] [Related]
17. Mu- and delta-opioid receptors inhibitorily linked to dopamine-sensitive adenylate cyclase in rat striatum display a selectivity profile toward endogenous opioid peptides different from that of presynaptic mu, delta and kappa receptors.
Schoffelmeer AN; De Vries TJ; Hogenboom F; Mulder AH
J Pharmacol Exp Ther; 1993 Oct; 267(1):205-10. PubMed ID: 8229747
[TBL] [Abstract][Full Text] [Related]
18. Stress-induced activation of ventral tegmental mu-opioid receptors reduces accumbens dopamine tone by enhancing dopamine transmission in the medial pre-frontal cortex.
Latagliata EC; Valzania A; Pascucci T; Campus P; Cabib S; Puglisi-Allegra S
Psychopharmacology (Berl); 2014 Oct; 231(21):4099-108. PubMed ID: 24958228
[TBL] [Abstract][Full Text] [Related]
19. The neurotensin analog NT69L enhances medial prefrontal cortical dopamine and acetylcholine efflux: potentiation of risperidone-, but not haloperidol-, induced dopamine efflux.
Prus AJ; Huang M; Li Z; Dai J; Meltzer HY
Brain Res; 2007 Dec; 1184():354-64. PubMed ID: 17988654
[TBL] [Abstract][Full Text] [Related]
20. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs. D-2 dopamine receptors.
Shippenberg TS; Bals-Kubik R; Herz A
J Pharmacol Exp Ther; 1993 Apr; 265(1):53-9. PubMed ID: 8386244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
